Holocene Advisors’s Arena Pharmaceuticals Inc ARNA Stock Holding History

Holocene Advisors’s Portfolio ARNA Stock Details ARNA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q3	–	Sell	-1,224,937	Closed	-$83.5M	–	1012
2021 Q2	$83.5M	Buy	1,224,937 +370,673	+43%	+$24.2M	0.47%	73
2021 Q1	$59.3M	Buy	854,264 +39,609	+5%	+$3.05M	0.37%	84
2020 Q4	$62.6M	Sell	814,655 -157,038	-16%	-$11.8M	0.39%	82
2020 Q3	$72.7M	Buy	971,693 +688,241	+243%	+$45.9M	0.55%	54
2020 Q2	$17.8M	Sell	283,452 -443,618	-61%	-$24.4M	0.16%	157
2020 Q1	$30.5M	Buy	+727,070	New	+$33.3M	0.33%	97

Other funds holding ARNA

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

ACA

Avoro Capital Advisors New York $11.1B AUM 207.82% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Alkeon Capital Management New York $74.1B AUM 71.18% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Janus Henderson Group London $209B AUM 37.72% 1-Year Est. Return

PAMS

Pictet Asset Management (Switzerland) Geneva 73, Switzerland $84.3B AUM 26.5% 1-Year Est. Return

APM

Avidity Partners Management Dallas, Texas $624M AUM 250.2% 1-Year Est. Return

Holocene Advisors's ARNA Position: Q3 2021 in Review

Holocene Advisors sold out of Arena Pharmaceuticals Inc (ARNA) in Q3 2021, closing a stake of 1,224,937 shares — an estimated $83.5M sold.

Holocene Advisors first reported a position in ARNA in Q1 2020 and held it in 6 quarters. The position peaked at $83.5M in Q2 2021. 235 funds tracked by Wall St. Rank hold ARNA as of Q3 2021.

Holocene Advisors reported no remaining Arena Pharmaceuticals Inc position as of Q3 2021 after selling out during the quarter.
Holocene Advisors sold 1,224,937 Arena Pharmaceuticals Inc shares in Q3 2021, an estimated $83.5M.
Holocene Advisors first reported a position in Arena Pharmaceuticals Inc in Q1 2020 and held it in 6 quarters.
Holocene Advisors's Arena Pharmaceuticals Inc position peaked at $83.5M in Q2 2021.
235 funds tracked by Wall St. Rank held Arena Pharmaceuticals Inc as of Q3 2021.

Based on Holocene Advisors's 13F filing for Q3 2021, filed 15 Nov 2021.